{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-112658","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2024-12-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.683235+00:00","generated_at":"2026-05-28T23:12:38.009945+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"China Pharma shareholders approve reverse stock split at 1:10–1:20; all directors elected","bullets":["All five director nominees elected: Zhilin Li, Heung Mei Tsui (non-independent), Gene Michael Bennett, Yingwen Zhang, Baowen Dong (independent).","Amendment to allow reverse stock split at ratio between 1:10 and 1:20 approved; board retains discretion to effect.","Amendment No.2 to the 2010 Long-Term Incentive Plan approved by shareholders.","Advisory vote on executive compensation approved; frequency set at every three years.","Annual meeting held Dec 22, 2024; quorum of ~52% (9,688,133 shares) of outstanding stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-112658","json":"https://secwatch.observer/filing/0001213900-24-112658.json","markdown":"https://secwatch.observer/filing/0001213900-24-112658.md","text":"https://secwatch.observer/filing/0001213900-24-112658.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024112658/0001213900-24-112658-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024112658/ea022580301-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:12:38.009945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}